| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Urology, University of Tennessee, Memphis, Tennessee 38163 [C. O'T.], and Department of General Oncology, Sahlgrenska Hospital, 413.45. Gothenberg, Sweden [B. U.]
Peripheral blood lymphocyte and leukocyte levels were monitored in 34 patients with bladder carcinoma before, during, and up to 5 years after radiotherapy. Radiotherapy in doses 6500 to 8500 rads caused a marked decline in the numbers of circulating leukocytes and particularly lymphocytes. In patients clinically free of disease for 5 years, lymphocyte counts returned to pretherapy levels within 3 years after radiotherapy. In contrast, in patients with recurrent or residual tumors lymphocyte counts failed to reach pretherapy levels within 3 years after therapy. The rate of recovery from radiation-induced lymphopenia was significantly different for patients who were free of disease as compared to those with recurrent or residual tumor (p < 0.05). No correlation was found between posttherapy leukocyte levels and clinical status.
1 This study was supported by Grant CA20216 from the National Cancer Institute, Department of Health, Education and Welfare and the Jönköping Cancer Fund for Clinical Research.
2 To whom requests for reprints should be addressed.
Received 6/ 8/78. Accepted 12/ 4/78.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |